3/8/2019 Contest update
Biotechs turned south after FDA Commissioner Scott Gottlieb announced his resignation on Tuesday. Meanwhile, the White House declined to comment regarding rumors Gottlieb would be replaced by Martin Shkreli.
At Friday’s close, the Contest median was up 15.90% YTD (vs. 20.41% YTD a week ago), the Nasdaq Biotech Index (NBI) was up 12.17% YTD (vs. 18.92% YTD a week ago), the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 19.94% YTD (vs. 27.54% YTD a week ago) and the Nasdaq Composite Index (NCI) was up 11.65% YTD (vs. up 14.47% YTD a week ago).
Defying rational expectation theory, BULBA’s portfolio, up 59.32% YTD, remained in first place. OHM’s portfolio, up 45.51% YTD, moved up to second place and SANCTU’s portfolio, up 42.82%, held on to third place.
At Friday's close, 37 of the 39 Contest portfolios were still in the green, with 26 beating the NBI and 17 now beating the SPSIBI.
The 167 Contest stock picks have an average YTD gain of 22.98% and a median YTD gain of 15.76%.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.)
Portfolio adjustments: None.
(All corrections, especially adjustments for splits & mergers, greatly appreciated.)
Enjoy a safe & fun weekend biotechies!
(And don’t forget to spring forward.)
Peace & good health,
Bulba
3/8/19
Rank Name Profit/Loss
1 BULBA 59,318
2 OHMS 45,512
3 SANCTU 42,822
4 HOOD 42,196
5 RKRW 37,926
6 JACKH 35,837
7 TRONKA 35,471
8 GHMM 35,463
9 ANDRE 35,134
10 BIOADD 26,754
Week's Top 5 Gainers
Symbol 3/1/19 3/8/19 Wk.%chg.
ARQL 3.560 5.080 42.70%
TCON 1.090 1.360 24.77%
AGRX 0.927 1.140 22.94%
RTTR 0.635 0.757 19.13%
LPTX 1.510 1.750 15.89%
Week's Worst 5 Losers
Symbol 3/1/19 3/8/19 Wk.%chg.
APVO 1.570 0.845 -46.18%
CDTX 3.080 2.400 -22.08%
CMRX 2.290 1.790 -21.83%
ABUS 4.570 3.700 -19.04%
ADAP 4.570 3.720 -18.60%
|
